Pay in 4 interest-free payments of $12.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
and FLT3-ITD/F691L in cellular assays
Formula: C15H22N2O4
Varenicline (2
InChi: InChI=1S/C24H29N7O2
Minegishi Y
TG101348 (SAR302503) - JAK2 and BRD4 Dual Inhibitor. CAS# 936091-26-8 size:2 mg solid and FLT3-ITD/F691L in cellular assaysTG101348, CAS No. 936091 26 8, is a potent, specific and orally bioavailable inhibitor of JAK2 (IC50 ~3 nM) and BRD4 (IC50 ~164 nM). It is 35 and 334 fold more selective for JAK2 versus JAK1 and JAK3. It also significantly inhibits JAK2 V617F, Flt3, and Ret with IC50 of 3 nM, 15 nM, and 48 nM, respectively. TG101348 induces apoptosis in both HEL and Ba F3 JAK2V617F cells, but not in normal human dermal fibroblasts at concentrations up to 10 uM, and
US$ 38.95
US$ 40.95
US$ 15.95
US$ 79.95
US$ 691.50
US$ 36.95
US$ 21.95
US$ 79.95
US$ 20.00